Savaria (TSE:SIS) Insider Jean-Philippe De Montigny Sells 10,000 Shares

Key Points

• Insider sale: Jean-Philippe De Montigny sold 10,000 Savaria shares at an average C$29.21, generating C$292,100. His remaining stake fell 10.8% to 82,560 shares.
• Stock performance: Savaria shares recently traded at C$29.40, near their 50-day average of C$29.28, with a market capitalization of approximately C$2.12 billion.
• Analyst outlook: Analysts maintain a consensus “Buy” rating, with an average price target of C$34.35; several firms recently raised their targets to between C$37 and C$39.

Savaria Co. (TSE:SIS - Get Free Report) insider Jean-Philippe De Montigny sold 10,000 shares of the company's stock in a transaction dated Monday, September 21st. The shares were sold at an average price of C$29.21, for a total transaction of C$292,100.00. Following the sale, the insider owned 82,560 shares of the company's stock, valued at C$2,411,577.60. This trade represents a 10.80% decrease in their ownership of the stock.

Savaria Stock Performance

Shares of Savaria stock traded up C$0.16 during trading on Tuesday, reaching C$29.40. The company's stock had a trading volume of 104,114 shares, compared to its average volume of 193,969. Savaria Co. has a one year low of C$20.10 and a one year high of C$31.95. The company has a debt-to-equity ratio of 29.43, a quick ratio of 0.91 and a current ratio of 1.72. The firm has a market cap of C$2.12 billion, a price-to-earnings ratio of 24.30, a price-to-earnings-growth ratio of 42.72 and a beta of 0.97. The business's fifty day moving average price is C$29.28 and its 200-day moving average price is C$28.62.

Savaria (TSE:SIS - Get Free Report) last released its earnings results on Wednesday, August 5th. The company reported C$0.35 earnings per share (EPS) for the quarter. Savaria had a return on equity of 13.41% and a net margin of 9.27%.The firm had revenue of C$245.78 million for the quarter. As a group, equities research analysts predict that Savaria Co. will post 1.2048518 earnings per share for the current year.

Analyst Upgrades and Downgrades

Several research firms have issued reports on SIS. TD Securities upgraded shares of Savaria to a "strong-buy" rating in a research report on Friday, July 24th. TD increased their target price on shares of Savaria from C$35.00 to C$37.00 and gave the company a "buy" rating in a research note on Friday, August 7th. Ventum Financial set a C$34.50 target price on Savaria and gave the stock a "buy" rating in a research report on Thursday, September 10th. ATB Cormark Capital Markets boosted their price target on Savaria from C$35.00 to C$38.00 and gave the company an "outperform" rating in a research note on Friday, August 7th. Finally, Desjardins upped their price target on Savaria from C$36.00 to C$39.00 and gave the company a "buy" rating in a report on Friday, August 7th. One research analyst has rated the stock with a Strong Buy rating and nine have issued a Buy rating to the company's stock. According to data from MarketBeat.com, Savaria presently has a consensus rating of "Buy" and an average price target of C$34.35.

About Savaria

Savaria Corporation ( savaria.com ) is a global leader in the accessibility industry. It provides accessibility solutions for the physically challenged to increase their comfort, their mobility and their independence. Its product line is one of the most comprehensive on the market. Savaria designs, manufactures, distributes and installs accessibility equipment, such as stairlifts for straight and curved stairs, vertical and inclined wheelchair lifts and elevators for home and commercial use. It also manufactures and markets a comprehensive selection of pressure management products for the medical market, medical beds for the long-term care market, as well as an extensive line of medical equipment and solutions for the safe handling of patients, including ceiling lifts and slings.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.